• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,186.87 1.44
( 0.00%)
Global Indices
Nasdaq
52,569.33 -110.31
(-0.21%)
Dow Jones
7,555.54 -37.86
(-0.50%)
Hang Seng
66,873.37 -1,878.14
(-2.73%)
Nikkei 225
10,555.24 39.32
(0.37%)
Forex
USD-INR
96.14 0.39
(0.40%)
EUR-INR
109.70 0.52
(0.48%)
GBP-INR
128.61 0.54
(0.42%)
JPY-INR
0.59 0.00
(0.41%)

EQUITY - MARKET SCREENER

Dr Lal Pathlabs Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
539524
INE600L01024
147.5152509
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LALPATHLAB
55.21
29070.9
EPS(TTM)
Face Value()
Div & Yield %
31.41
10
1.18
 

NBCC (India) consolidated net profit rises 37.22% in the March 2026 quarter
May 25,2026
Net profit of NBCC (India) rose 37.22% to Rs 241.39 crore in the quarter ended March 2026 as against Rs 175.92 crore during the previous quarter ended March 2025. Sales declined 1.81% to Rs 4559.80 crore in the quarter ended March 2026 as against Rs 4643.85 crore during the previous quarter ended March 2025.

For the full year,net profit rose 33.06% to Rs 720.03 crore in the year ended March 2026 as against Rs 541.13 crore during the previous year ended March 2025. Sales rose 7.01% to Rs 12888.61 crore in the year ended March 2026 as against Rs 12043.78 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4559.804643.85 -2 12888.6112043.78 7
OPM %6.306.27 -4.795.22 -
PBDT346.18347.97 -1 924.23858.41 8
PBT342.29345.01 -1 911.16850.98 7
NP241.39175.92 37 720.03541.13 33